Stockreport

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting [Yahoo! Finance]

Zymeworks Inc.  (ZYME) 
Last zymeworks inc. earnings: 3/2 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.zymeworks.com/overview
PDF Strong preclinical activity across multiple FRa-expressing indications for ZW191, a FRa-targeting antibody-drug conjugate Next generation trispecific T cell engager p [Read more]